Navigation Links
Applied Computational Technologies Appoints a New CEO
Date:6/16/2008

Kathy Blum Will Help Drive the Commercialization of Company's Cancer

Therapy Product

PITTSBURGH, June 16 /PRNewswire/ -- Applied Computational Technologies (AppCompTech) has announced the appointment of Kathy Blum as the company's new Chief Executive Officer. With extensive experience in leading medical device, service and IT related businesses as well as global experience with start-ups and Fortune 500 organizations, Ms. Blum brings 27 years of industry knowledge and leadership with her as the new CEO of Applied Computational Technologies.

As CEO, Ms. Blum will be driving AppCompTech's mission to provide advanced radiation oncology treatment planning with ProACTive(TM) -- the company's groundbreaking software technology that is a dose calculation module which provides increased accuracy and greater speed in planning targeted radiation treatment.

"Ms. Blum will play a critical role in raising our final round of investment funding and positioning Applied Computational Technologies in the radiation therapy systems market," said Jay McClatchey, AppCompTech Co-founder. "Our software blends incredible speed with accuracy, enabling adaptive planning for a significant competitive advantage over existing treatment technology. We are all looking forward to working together to complete testing and bring our product ProACTive to market."

"In 2008 an estimated 1.4 million Americans will be diagnosed with cancer and approximately 65% of those cancer victims will receive some form of radiation therapy," said Ms. Blum. "I am honored to be part of an organization that is developing a product that can make radiation therapy more efficient and effective and help save more lives."

In addition, AppCompTech has formed an important strategic partnership with D3 Radiation Planning, a UPMC affiliated radiation oncology service company that offers advanced radiation treatment planning to hospitals and freestanding ins
'/>"/>

SOURCE Applied Computational Technologies
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Applied Isotope Technologies will Exclusively Supply Biochemimarker(TM) Discovery Products for a Unique Pilot Study on Autism
2. Hershey Center for Applied Research Supports Acceleration of Scientific Research and Development
3. Microfluidic Systems Announces Agreements With Applied Biosystems and United Technologies Hamilton Sundstrand Division for Production of Bioagent Autonomous Networked Detector System
4. DuPont Names Nicholas Fanandakis as Group Vice President - DuPont Applied BioSciences
5. Study Examines Media Preferences of Life Scientists in Applied Markets
6. Fundamental Applied Biology, Inc. Completes $21 Million Series B Financing
7. Emisphere Technologies, Inc. Appoints Gary Riley as Vice President Nonclinical Development & Applied Biology
8. PAL Health Technologies Debuts Xtremityscan System at Western Podiatric Medical Congress
9. Senesco Technologies to Present at BIO 2008 Business Forum
10. BioSpecifics Technologies Corp. Announces Additional Sales of Stock in Private Placement Offering
11. Spine Surgeons at Pine Creek Medical Center Take the Lead in Utilizing Stem Cell Technologies in Surgical Procedures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2015)...  The Diabetes Research Institute (DRI), a Center ... School of Medicine, announced today that the first ... the first time a novel transplant technique for ... Phase I/II study builds upon decades of progress ... first step toward the development of the DRI ...
(Date:8/26/2015)... -- Intrexon Corporation (NYSE: XON ), a leader ... previously announced public offering of common stock, including the ... to purchase an additional 731,707 shares of common stock ...  The exercise of the underwriters, option brought the total ... to 5,609,756 shares and increased the total gross proceeds ...
(Date:8/26/2015)... HONG KONG , Aug. 26, 2015 ... "Company"), China,s leading provider of ... and stem cell storage services, today announced that the ... Holdings Limited ("MO2"), an entity wholly owned by Mr. ... the Company, has acquired the outstanding shares (the "Shares") ...
(Date:8/26/2015)... CORAL SPRINGS, Florida , August 26, 2015 ... one of the biggest factors fueling the optimism ... FDA approvals, M&A,s, collaborations and life sciences advancements.  ... and developments are Pressure BioSciences, Inc. (OTCQB: PBIO), ... Inc. (NASDAQ: SRPT ), Raptor Pharmaceutical Corp. ...
Breaking Biology Technology:Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 2Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 3Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 4Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 2Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 3Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 4China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 2China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 3New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 2New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 3New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 4New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 5New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 6New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 7
... Westerners Return from Beijing,s World-Class Stem Cell Treatment ... with Clear Improvement, Giving Hope Not Found ... Puhua Neurosurgical,Hospital, the world,s leading center for effective ... today here announced that four more,international patients returned ...
... Strategic Focus on Growth-Driving Global Products, BASINGSTOKE, ... SHPGY, TSX: SHQ), the global specialty biopharmaceutical,company, announces ... of non core,products to Almirall for a cash ... SOLARAZE(R) (3% gel diclofenac sodium),and VANIQA(R) (eflornithine hydrochloride), ...
... more about the origins of quantum dot blinking, ... National Laboratory, the University of Chicago and the ... to characterize it on faster time scales than ... material, also known as quantum dots, are being ...
Cached Biology Technology:American and European Parkinson's Sufferers Find Chinese Stem Cell Treatment Effective, Proving Western Debates Moot 2American and European Parkinson's Sufferers Find Chinese Stem Cell Treatment Effective, Proving Western Debates Moot 3American and European Parkinson's Sufferers Find Chinese Stem Cell Treatment Effective, Proving Western Debates Moot 4Shire Divests Non-Core Product Portfolio to Almirall 2Shire Divests Non-Core Product Portfolio to Almirall 3Argonne researcher studies what makes quantum dots blink 2
(Date:8/18/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/9dmm6l/global_biometric ... "Global Biometric Authentication & Identification Market: Focus On ... 2015-2020" report to their offering. ... market is expected to grow at an estimated ... generate over $25 billion (approximately) by 2020 as ...
(Date:8/12/2015)... Aug. 12, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced that four of its fingerprint ... have officially been named FIDO Certified™ by the ... the certification, Synaptics, Natural ID™ fingerprint solutions are ... Framework (UAF) standard and are interoperable among other ...
(Date:8/6/2015)... and TELTOW, Germany , August 6, ... Conference, SensoMotoric Instruments (SMI) shows the world,s ... , based on Epson,s Moverio BT-200 see-through head ... With this new solution, unprecedented quality and efficiency is ... with context-sensitive displays. For the first time, professionals and ...
Breaking Biology News(10 mins):Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 3SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3
... A new minute freshwater snail species belonging to the genus ... Athens (Canella Radea) in a spring covered by snow on ... access journal Zookeys . The ... shell, grey-black pigmented soft body and a black penis with a ...
... scientists may lead to a pharmaceutical breakthrough for a ... cells that line the inner surfaces of our body,s ... the FASEB Journal ( http://www.fasebj.org ), the ... small-molecule drug candidates which help cells bypass defective channels ...
... how humans develop immunity to malaria, and could ... Dr Alyssa Barry from the Walter and ... using ,protein microarray, technology to screen human blood ... the malaria-causing Plasmodium falciparum parasite. Her research, which ...
Cached Biology News:Scientists discover new drug candidates for cystic fibrosis and other diseases 2'Protein microarrays' may reveal new weapons against malaria 2
Rabbit polyclonal to WWOX8 ( Abpromise for all tested applications). entrezGeneID: 51741 SwissProtID: Q9NZC7-8...
Goat polyclonal to T7 tag (Agarose) Immunogen: Goats were immunized with MASMTGGQQMG (T7) conjugated to KLH.After multiple immunizations in Freund's adjuvant, serum was collected....
Rabbit polyclonal to Olfactory Receptor LS189744 ( Abpromise for all tested applications)....
Ubiquitin-like protein 4A (Ubiquitin-like protein GDX). [Source:Uniprot/SWISSPROT;Acc:P11441] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products: